.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Farmers Insurance
McKinsey
Baxter
Cerilliant
Teva
Colorcon
Novartis
UBS
Boehringer Ingelheim
Queensland Health

Generated: September 22, 2017

DrugPatentWatch Database Preview

Prednisone - Generic Drug Details

« Back to Dashboard

What are the generic sources for prednisone and what is the scope of prednisone freedom to operate?

Prednisone
is the generic ingredient in thirteen branded drugs marketed by Halsey, West-ward Pharms Int, Marshall Pharma, Mutual Pharm, Vangard, Inwood Labs, Vitarine, Phoenix Labs Ny, Solvay, Contract Pharmacal, Roxane, Muro, Elkins Sinn, Jubilant Cadista, Aurolife Pharma Llc, Watson Labs, Whiteworth Town Plsn, Lannett, Nylos, Heather, Horizon Pharma, Lederle, Wockhardt, Mylan Pharms Inc, Rexall, Ivax Sub Teva Pharms, Kv Pharm, Sandoz, Valeant Pharm Intl, Hikma Pharms, Everylife, Sun Pharm Inds, Panray, Pvt Form, Purepac Pharm, Schwarz Pharma, Vintage Pharms, Chartwell Rx, Sperti, Parke Davis, Pharmavite, Ferrante, Ferndale Labs, Superpharm, Schering, Actavis Labs Fl Inc, Upsher Smith, Scherer Labs, Bundy, Impax Labs, UDL, Pharmacia And Upjohn, Am Therap, Bayer Pharms, Duramed Pharms Barr, Amneal Pharms Ny, and Teva, and is included in one hundred and nineteen NDAs. There are eight patents protecting this compound and one Paragraph IV challenge. Additional information is available in the individual branded drug profile pages.

Prednisone has sixty patent family members in twenty-eight countries.

There are sixteen drug master file entries for prednisone. Fifty-eight suppliers are listed for this compound.

Summary for Generic Name: prednisone

Tradenames:13
Patents:8
Applicants:57
NDAs:119
Drug Master File Entries: see list16
Suppliers / Packagers: see list58
Bulk Api Vendors: see list50
Clinical Trials: see list1,310
Patent Applications: see list9,961
Therapeutic Class:Inflammatory Bowel Disease Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:prednisone at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
West-ward Pharms Int
PREDNISONE
prednisone
TABLET;ORAL084122-001Approved Prior to Jan 1, 1982ABRXNoYes► Subscribe► Subscribe► Subscribe
Nylos
PREDNISONE
prednisone
TABLET;ORAL085115-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
West-ward Pharms Int
PREDNISONE
prednisone
TABLET;ORAL087801-001Apr 22, 1982ABRXNoYes► Subscribe► Subscribe► Subscribe
Watson Labs
PREDNISONE
prednisone
TABLET;ORAL085162-001Approved Prior to Jan 1, 1982ABRXNoNo► Subscribe► Subscribe► Subscribe
Elkins Sinn
PREDNISONE
prednisone
TABLET;ORAL080491-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Horizon Pharma
RAYOS
prednisone
TABLET, DELAYED RELEASE;ORAL202020-001Jul 26, 2012ABRXYesNo► Subscribe► SubscribeY ► Subscribe
Vangard
PREDNISONE
prednisone
TABLET;ORAL087682-001Jan 15, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Pharmacia And Upjohn
DELTASONE
prednisone
TABLET;ORAL009986-007Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe► Subscribe
Scherer Labs
PREDNISONE
prednisone
TABLET;ORAL080371-001Approved Prior to Jan 1, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe
Horizon Pharma
RAYOS
prednisone
TABLET, DELAYED RELEASE;ORAL202020-003Jul 26, 2012ABRXYesYes► Subscribe► Subscribe ► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Generic Ingredient: prednisone

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
8,920,838Delayed-release glucocorticoid treatment of rheumatoid disease► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: prednisone

Country Document Number Estimated Expiration
South Korea101192722► Subscribe
European Patent Office1158988► Subscribe
Israel171494► Subscribe
Australia2004231362► Subscribe
Spain2400446► Subscribe
World Intellectual Property Organization (WIPO)0224206► Subscribe
Australia3179000► Subscribe
Russian Federation2005132451► Subscribe
Spain2368066► Subscribe
Portugal1631251► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

US Army
Colorcon
Cantor Fitzgerald
McKinsey
Covington
Fuji
Mallinckrodt
Healthtrust
Farmers Insurance
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot